Guild admits it was ‘blindsided’ by PSA signatory announcement

It was also ‘perplexed’ about the Health Minister’s decision to announce dual listing of medicines without consultation There has been a concerning lack of consultation regarding significant decisions that have been made by the Health Minister in recent months, said Guild executive director Pam Price at the PharmaDispatch 2019 conference in Sydney on Monday. The

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Doc group ‘misguided and ill-informed’ on flu vax: Dowling